Leonel Hernandez Aya

Assistant Professor of Medicine

    • 1338 Citations

    Research output per year

    If you made any changes in Pure these will be visible here soon.

    Fingerprint Dive into the research topics where Leonel Hernandez Aya is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

    • 6 Similar Profiles

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output

    Adenosine 2A receptor blockade as an immunotherapy for treatment-refractory renal cell cancer

    Fong, L., Hotson, A., Powderly, J. D., Sznol, M., Heist, R. S., Choueiri, T. K., George, S., Hughes, B. G. M., Hellmann, M. D., Shepard, D. R., Rini, B. I., Kummar, S., Weise, A. M., Riese, M. J., Markman, B., Emens, L. A., Mahadevan, D., Luke, J. J., Laport, G., Brody, J. D. & 13 others, Hernandez-Aya, L., Bonomi, P., Goldman, J. W., Berim, L., Renouf, D. J., Goodwin, R. A., Munneke, B., Ho, P. Y., Hsieh, J., McCaffery, I., Kwei, L., Willingham, S. B. & Miller, R. A., Jan 2020, In : Cancer discovery. 10, 1, p. 40-53 14 p.

    Research output: Contribution to journalArticle

    Open Access
  • 21 Scopus citations

    A phase ii study of glembatumumab vedotin for metastatic uveal melanoma

    Hasanov, M., Rioth, M. J., Kendra, K., Hernandez-Aya, L., Joseph, R. W., Williamson, S., Chandra, S., Shirai, K., Turner, C. D., Lewis, K., Crowley, E., Moscow, J., Carter, B. & Patel, S., Aug 2020, In : Cancers. 12, 8, p. 1-12 12 p., 2270.

    Research output: Contribution to journalArticle

    Open Access
  • Association between Immune-Related Adverse Events and Recurrence-Free Survival among Patients with Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial

    Eggermont, A. M. M., Kicinski, M., Blank, C. U., Mandala, M., Long, G. V., Atkinson, V., Dalle, S., Haydon, A., Khattak, A., Carlino, M. S., Sandhu, S., Larkin, J., Puig, S., Ascierto, P. A., Rutkowski, P., Schadendorf, D., Koornstra, R., Hernandez-Aya, L., Di Giacomo, A. M., Van Den Eertwegh, A. J. M. & 10 others, Grob, J. J., Gutzmer, R., Jamal, R., Lorigan, P. C., Krepler, C., Ibrahim, N., Marreaud, S., Van Akkooi, A., Robert, C. & Suciu, S., Apr 2020, In : JAMA oncology. 6, 4, p. 519-527 9 p.

    Research output: Contribution to journalArticle

    Open Access
  • 21 Scopus citations

    Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

    Migden, M. R., Khushalani, N. I., Chang, A. L. S., Lewis, K. D., Schmults, C. D., Hernandez-Aya, L., Meier, F., Schadendorf, D., Guminski, A., Hauschild, A., Wong, D. J., Daniels, G. A., Berking, C., Jankovic, V., Stankevich, E., Booth, J., Li, S., Weinreich, D. M., Yancopoulos, G. D., Lowy, I. & 2 others, Fury, M. G. & Rischin, D., Feb 2020, In : The Lancet Oncology. 21, 2, p. 294-305 12 p.

    Research output: Contribution to journalArticle

  • 15 Scopus citations

    Palliative single-fraction whole liver radiation therapy for diffuse liver metastases from metastatic Merkel cell carcinoma

    Andruska, N., Mahapatra, L., Brenneman, R., Hernandez-Aya, L. F., MacArthur, K. M. & Baumann, B. C., 2020, (Accepted/In press) In : Journal of Dermatology.

    Research output: Contribution to journalLetter